Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,52 USD | 0,00% | 0,00% | -30,99% |
28/03 | Zevra Therapeutics, Inc. rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
28/03 | Transcript : Zevra Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Vakgebied
Aantal werknemers: 67
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Proprietary Prodrugs
100,0
%
| 10 | 100,0 % | 27 | 100,0 % | +162,58% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States and Europe
100,0
%
| 10 | 100,0 % | 27 | 100,0 % | +162,58% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Christal Mickle
FOU | Founder | 45 | 30-10-06 |
Neil McFarlane
CEO | Chief Executive Officer | 51 | 10-10-23 |
R. Clifton
DFI | Director of Finance/CFO | 51 | 01-04-15 |
Daniel Gallo
CTO | Chief Tech/Sci/R&D Officer | - | 31-01-23 |
Adrian Quartel
CTO | Chief Tech/Sci/R&D Officer | 63 | 04/01 |
Sven Guenther
CTO | Chief Tech/Sci/R&D Officer | 52 | 01-01-07 |
Nichol Ochsner
IRC | Investor Relations Contact | - | 09-08-22 |
Abbi Maher
LAW | General Counsel | - | 31-01-23 |
Joshua Schafer
PRN | Corporate Officer/Principal | 53 | 09-01-23 |
Comptroller/Controller/Auditor | 40 | 13-02-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wendy Dixon
BRD | Director/Board Member | 68 | 25-04-23 |
Tamara Favorito
CHM | Chairman | 65 | 18-08-21 |
Director/Board Member | 56 | 25-04-23 | |
Christal Mickle
FOU | Founder | 45 | 30-10-06 |
Sven Guenther
CTO | Chief Tech/Sci/R&D Officer | 52 | 01-01-07 |
Corey Watton
BRD | Director/Board Member | 54 | 25-04-23 |
John Bode
BRD | Director/Board Member | 49 | 25-04-23 |
Thomas Anderson
BRD | Director/Board Member | 68 | 07-08-23 |
Alvin Shih
BRD | Director/Board Member | 47 | 20/01 |
Neil McFarlane
CEO | Chief Executive Officer | 51 | 10-10-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 45 001 878 | 39 916 898 ( 88,70 %) | 1 575 692 ( 3,501 %) | 88,70 % |
Bedrijfsgegevens
Zevra Therapeutics, Inc.
1180 Celebration Boulevard Suite 103
34747, Celebration
+321 939 3416
http://zevra.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-30,99% | 189 mln. | |
+5,31% | 70,44 mld. | |
+10,97% | 8,94 mld. | |
-16,83% | 4,75 mld. | |
+43,48% | 4,5 mld. | |
+3,20% | 3,85 mld. | |
+18,82% | 2,38 mld. | |
-21,36% | 2,34 mld. | |
-29,67% | 2,2 mld. | |
+8,38% | 1,96 mld. |
- Beurs
- Aandelen
- Koers ZVRA
- Onderneming Zevra Therapeutics, Inc.